Drug Screening Market - Growth Strategy Adopted by Key Vendors
The global drug screening market is projected to reach USD
11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during
the forecast period.
To know about the assumptions considered for the study
download the pdf brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
Growth in this market is attributed to the growing drug
& alcohol consumption and the enforcement of stringent laws mandating drug
& alcohol testing, rising regulatory approvals for drug screening products
& services
Global Drug Screening Market Scope:
|
Metrics |
Details |
|
Study Period |
2019–2026 |
|
Market Size in 2025 |
USD 11.6 Billion |
|
Segment Covered |
Product & Service, Sample type,
End User, and Region |
|
by product Covered |
Consumables, Urine Testing Devices,
Analytical, Breathalyzer, Chromatography, Immunoassay |
|
by Service Type Covered |
Urine, Breath |
|
By enduser Covered |
Workplace, Laboratories, Criminal
Justice, Hospitals |
|
Regions Covered |
North America, Europe, Asia Pacific,
Middle East and Africa, and South America |
|
Key Players Profiled |
LabCorp (US), Quest Diagnostics (US),
Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa
Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens
Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan),
LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US),
Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference
Laboratory (US) |
LabCorp (US): LabCorp is a leading player in the US
drug screening services market. The company’s leading position is attributed to
its wide drug testing portfolio, including over 4,800 tests. The company has a
strong brand name and robust service portfolio, which provides drug screening
services to managed care organizations, governmental agencies, healthcare
providers, hospitals and health systems, employers, patients, consumers,
contract research organizations, food and nutritional companies, and
independent clinical laboratories.
Abbott Laboratories (US): Abbott Laboratories has a
strong product portfolio, and its FDA and CE Mark-approved products have helped
the company enhance its presence in the drug screening market. Abbott provides
abuse testing products and services for many settings such as hospitals,
physician offices, criminal justice agencies, workplaces, rehabilitation
centers, occupational health clinics, and homes.
Click Here to Access a Free Sample Report of the Global Autoinjectors
Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
Recent Developments
·
In August 2021, Quest Diagnostics and Select
Health of South Carolina entered into an agreement to expand Select Health’s
laboratory network for its Medicaid and Medicare-Medicaid dual-eligible
enrollees and to enhance access to diagnostics information services for
members.
·
LabCorp Entered into a multi-year agreement with
Infirmary Health (US) to offer laboratory testing services in the eastern Gulf
Coast.
·
Psychemedics introduced a vaping panel test that
detects the ingestion of marijuana, CBD, and nicotine drugs by all methods,
including electronic cigarettes or smoking
Our Free Sample Report Consists of the following:
·
Introduction, Overview, and in-depth industry
analysis are all included in the 2022 updated report.
·
The COVID-19 Pandemic Outbreak Impact Analysis
is included in the package
·
About 220+ Pages Research Report (Including
Recent Research)
·
Provide detailed chapter-by-chapter guidance on
Request
·
Updated Regional Analysis with Graphical
Representation of Size, Share, and Trends for the Year 2022
·
Includes Tables and figures have been updated
·
The most recent version of the report includes
the Top Market Players, their Business Strategies, Sales Volume, and Revenue
Analysis
Directly Purchase a copy of the report [223] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=162987773
Comments
Post a Comment